News Foley Represents Upload Ventures as Investor in $120 M Series C Financing for Tractian Foley & Lardner LLP represented Upload Ventures as an investor in the $120 million Series…Andre ThiollierDecember 19, 2024
News Brian Wheeler Quoted on Dealmaking in GP-led Secondaries Market Foley & Lardner LLP partner Brian Wheeler commented in the Pitchbook article, “GP-led secondaries to end 2024…Brian WheelerDecember 13, 2024
News Louis Lehot on Venture Market Liquidity, Outlook for 2025 – ‘I don’t think it’s as rosy as people thought’ Foley & Lardner LLP partner Louis Lehot shared insight in The Wall Street Journal article, “Lack of…Louis LehotDecember 9, 2024
News Louis Lehot and Brian Wheeler Discussing Dealmaking in 2025 Foley & Lardner LLP partners Louis Lehot and Brian Wheeler discussed dealmaking prospects in the…Louis LehotDecember 6, 2024
News Louis Lehot Explores Costs for Startups Launching Your Startup? Consider Your Costs This article was originally published in IPWatchdog on November 12, 2024,…Louis LehotNovember 19, 2024
News Louis Lehot Assesses 2024 Election Result, Prospect of Tech Deal Resurgence Foley & Lardner LLP partner Louis Lehot appeared across legal and business press to discuss…Louis LehotNovember 8, 2024
News Louis Lehot on OpenAI Corporate Overhaul – ‘Who will be the guardrails to the public good?’ Foley & Lardner LLP partner Louis Lehot commented on leadership and structural changes at OpenAI…Louis LehotSeptember 27, 2024
News Foley Represents ReferPro in $2.7M Seed Round Foley & Lardner LLP served as legal advisor to ReferPro.com, the referral automation software designed…Jeffrey BowmanSeptember 19, 2024
News Foley Represents Brazilian Health Care Startup Mevo in $19M Series B Funding Round Foley & Lardner LLP represented Mevo, a Brazilian health care startup, in its $19 million…Andre ThiollierSeptember 19, 2024
News Foley Represents TCGX as Lead Investor in $105M Series B Financing for Pathalys Pharma Foley & Lardner LLP represented TCG Crossover (TCGX) as the lead investor in the $105…Louis LehotSeptember 17, 2024